Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Novel 5-lipoxygenase inhibitors described by Pfizer

July 12, 1996

Naphthoquinone derivative selected as potential antiallergic/antiinflammatory

July 5, 1996

Uriach research into PAF antagonists continues

July 5, 1996

New beclomethasone formulation cleared for marketing

July 5, 1996

Trials terminated for HyperGAM+ for Pseudomonas lung infections

June 28, 1996

FK-506 undergoes phase II trials

June 28, 1996

Adenosine A3 antagonists from Merck & Co.

June 28, 1996

Eisai's ER-27319: Potential in treating allergic diseases

June 28, 1996

GCC-AP0341: Green Cross' eosinophilia inhibitor

June 28, 1996

5-lipoxygenase and cyclooxygenase inhibitors from Abbott

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...